Detected Huge Urinoma With 99mTc-PSMA Activity on Initial Prostate Cancer Staging.

Clin Nucl MedSep 8, 2026 (epub)

Mohammad Ahmadi, Mohammad H Samadi, Amin Saber Tanha et al.

✦ AI-curated · Sources linked

Case in brief

A 62-year-old man with newly diagnosed prostate adenocarcinoma underwent staging with 99mTc-PSMA and 99mTc-MDP scans. The bone scan indicated tracer activity near the left kidney, which was further evaluated with 99mTc-PSMA SPECT/CT, revealing a fluid density collection in the left perinephric space. Contrast-enhanced CT confirmed the diagnosis of urinoma, highlighting the need for careful interpretation of imaging findings.

What made this case unusual

The case is notable for the detection of a large urinoma associated with 99mTc-PSMA activity, which is an atypical finding in prostate cancer staging.

Diagnostic / clinical pearl

Clinicians should be aware that atypical patterns of 99mTc-PSMA uptake may indicate underlying conditions such as urinoma, which can affect patient management.

Why it matters

Recognizing these atypical imaging findings can prevent misinterpretation and ensure timely and appropriate interventions for patients with prostate cancer.

Source

Published in Clin Nucl Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Nuclear Medicine

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.